Drug Discovery Technologies Market worth $51.51 billion in 2030
The Report "Drug Discovery Technologies Market by Product (Instruments, Reagents, Software), Technology (HTS, NGS, PCR, AI-based, Lab-on-chip), Process (Target Identification, Validation, Lead Optimization), Therapeutic Area (Oncology, CVD) - Global Forecast to 2030" is projected to grow from USD 30.58 billion in 2025 and to reach USD 51.51 billion in 2030, at a Compound Annual Growth Rate (CAGR) of 11.0% during the forecast period.
Browse 400 market data Tables and 50 Figures spread through 450 Pages and in-depth TOC on "Drug Discovery Technologies Market by Product (Instruments, Reagents, Software), Technology (HTS, NGS, PCR, AI-based, Lab-on-chip), Process (Target Identification, Validation, Lead Optimization), Therapeutic Area (Oncology, CVD) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/drug-discovery-technologies-market-35597436.html
The Drug Discovery Technologies Market is expanding because of the increasing number of outsourced research and development stages of drugs. Drug manufacturers have started using these technologies to enhance the success rate of drug discoveries. The emphasis on molecules, biologics, and targeted therapies is increasing the demand for screening, target validation, and lead optimization services. The increase in diseases, cancer pipelines, and rare disease research is fueling market expansion. Technologies such as high-throughput screening and advanced cell-based assays help improve accuracy and support better decision-making. However, high development costs, difficulty in managing complex and large datasets, and a shortage of skilled professionals continue to slow market growth.
By technology, the high-throughput screening segment held the largest share of the drug discovery technologies market in 2024.
By technology, the drug discovery technologies market is segmented into high-throughput screening technologies, next-generation sequencing, polymerase chain reaction, in-silico/AI-based drug discovery technologies, X-ray crystallography, chromatography, mass spectrometry, and other technologies. In 2024, high-throughput screening accounted for the largest market share. This is because high-throughput screening facilitates the rapid screening of a huge number of compounds within a short period of time against biological targets. Technology has immense applications in the drug discovery stages of organizations associated with the pharmaceutical and biotechnology industries.
By therapeutic area, the oncology segment accounted for the largest share of the drug discovery technologies market in 2024.
By therapeutic area, the drug discovery technologies market is segmented into oncology, infectious diseases, cardiovascular diseases, neurological diseases, endocrine & metabolic diseases, autoimmune disorders, and other therapeutic areas. In 2024, oncology held the largest share in the drug discovery technologies market. This is attributed to the number of cancer research initiatives and an increased emphasis on targeted and personalized treatment approaches. Pharmaceutical companies utilize modern discovery tools to identify new drug targets, test large numbers of compounds, and select more effective lead candidates. The growing number of cancer cases, strong clinical pipelines, and steady funding from public and private sources continue to support the leading position of the oncology segment.
By region, North America accounted for the largest share of the market in 2024.
In 2024, North America held the largest share of the drug discovery technologies market. This is backed by a pharmaceutical and biotech foundation, along with the swift uptake of cutting-edge discovery tools. The US stands at the forefront in research funding, technological advancements, and regulatory encouragement for drug creation. The strong presence of contract research organizations, research institutes, and large pharmaceutical companies increases demand for screening, data analysis, and modeling tools. Ongoing clinical programs, steady funding, and close industry–research collaboration further support market growth in North America.
Some of the leading players in the market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Illumina, Inc. (US), Revvity, (US), F. Hoffmann-La Roche Ltd (Switzerland), Bruker (US), QIAGEN (Germany), and Bio-Rad Laboratories, Inc. (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Drug Discovery Technologies Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
